Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Journal of Medical Internet Research

Date Submitted: Aug 6, 2021
Date Accepted: Nov 30, 2021
Date Submitted to PubMed: Dec 21, 2021

The final, peer-reviewed published version of this preprint can be found here:

The Role of Unobtrusive Home-Based Continuous Sensing in the Management of Postacute Sequelae of SARS CoV-2

Corman BHP, Rajupet S, Ye F, Schoenfeld ER

The Role of Unobtrusive Home-Based Continuous Sensing in the Management of Postacute Sequelae of SARS CoV-2

J Med Internet Res 2022;24(1):e32713

DOI: 10.2196/32713

PMID: 34932496

PMCID: 8989385

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

The Role of Unobtrusive Continuous Sensing in the Diagnosis and Management of Post-Acute Sequelae of SARS CoV-2

  • Benjamin Harris Peterson Corman; 
  • Sritha Rajupet; 
  • Fan Ye; 
  • Elinor Randi Schoenfeld

ABSTRACT

Amid the COVID-19 pandemic, it has been reported that greater than 10% of patients with confirmed or suspected COVID-19 develop post-acute sequelae of SARS CoV-2 (PASC). PASC is still a disease for which preliminary medical data is being collected and pathophysiological understanding is yet in its infancy. The disease is notable for its prevalence and its variable symptom presentation and as such, diagnoses and management plans could be more holistically made if health care providers had access to unobtrusive continuous physiologic and physical sensor data at home. Such sensors would be able to provide vital sign and activity measurements that correlate directly or by proxy to documented PASC symptoms. These data can be collected at time points between hospital visits and can give care providers contextualized information from which symptom exacerbation or relieving factors may be classified. Such data can also improve the collective academic understanding of PASC by providing temporally and activity-associated symptom cataloging. In this viewpoint, we make a case for the utilization of sensor technologies that can serve as a foundation from which medical professionals and engineers may develop and pursue long-term mitigation strategies in conjunction with those ongoing in the acute setting.


 Citation

Please cite as:

Corman BHP, Rajupet S, Ye F, Schoenfeld ER

The Role of Unobtrusive Home-Based Continuous Sensing in the Management of Postacute Sequelae of SARS CoV-2

J Med Internet Res 2022;24(1):e32713

DOI: 10.2196/32713

PMID: 34932496

PMCID: 8989385

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.